pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
Clinical trial NCT06253507 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06253507
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2027-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.